Hybridan Small Cap Feast: 22/10/2024
* A corporate client of Hybridan LLP
** Potential means Intention to Float (ITF) has been announced, or it is a rumour
***Arranged by type of listing and date of announcement
****Alphabetically arranged
Share prices and market capitalisations taken from the current price on the day of publication
Dish of the day
Admissions:
None
Delistings:
Cambria Africa (CMB.L) has left AIM.
What’s baking in the oven?
ITF announced:***
Potential** Initial Public Offerings:
30th September 2024: Applied Nutrition, the sports nutrition, health and wellness brand has confirmed its intention to float on the LSE Main Market. The Group sells approximately 100 different products, with flavour and format combinations across those products resulting in over 500 stock keeping units. July 2024 YE numbers reported revenue of £86m and EBITDA of £25.9m. The Offer will compromise existing shares to be sold by certain existing shareholders of the Company. Any additional details in relation to the Offer, together with any changes to corporate governance arrangements, will be disclosed in a Prospectus, if and when published.
17th October 2024: Selkirk Group, a newly incorporated company established with the primary objective of acquiring a company or business which the Directors believe is undervalued and providing them with their own listing on the AIM market to create shareholder value or acquiring an existing public company and providing a highly incentivised management team with strategic direction. The Company is focused on acquiring business which are headquartered in the UK. The Company is primarily focused on the small and mid-cap market, specifically within the Consumer, Technology and digital media related sectors. Expected first day of trading in late October with an expected size of primary offer of £7.5m.
The global specialist staffing group announced an update on trading. The challenging, industry wide, market conditions that have persisted for the last two years continue to adversely impact the Group with conditions worsening in a number of markets and permanent recruitment demand generally remaining extremely subdued. Adverse trading conditions are expected to continue through the first half of 2025. As a result, full year adjusted profit before tax is now expected to be no less than £2.0m.
The UK based online retailer of musical instruments and music equipment announced a trading update for the six months to 30 September 2024. FY25 H1 revenues were £61.7m (FY24 H1 revenue £62.6m) and gross margin expected to be 26.7%, a small decrease on FY24 H1 (27.1%). Gross profit expected to be £16.5m (FY24 H1: £17.0m), with EBITDA expected to be £2.9m (FY24 H1 reported EBITDA £2.4m). Net debt reduced by £3.6m to £14.5m at 30 September 2024 (FY24 H1: £18.1m, FY23 H1: £21.8m).
The engineering specialist in electronic and electro-mechanical components and systems announced the appointment of Philo Daniel-Tran as Chief Executive Officer who will join LPA as a director of the Company in January 2025. Philo has experience working in Transport, Defence and Security sectors across the globe. Until recently, Philo was Global Director Aviation & Urban Security at Smiths Detection, a major division of Smiths Group, where she oversaw the restructure of the Aviation sub-division focussing on delivery, strategic growth, and introduction of new technologies.
The sustainable process technology developer announced the official inauguration by Mercedes-Benz of its integrated mechanical-hydrometallurgical lithium-ion battery recycling plant in Kuppenheim, Germany, which uses the technology of Neometals' 50:50 incorporated JV (Primobius GmbH). Primobius is an incorporated battery recycling joint venture company, owned 50:50 by Neometals and SMS group GmbH. Primobius is commercialising a patented lithium-ion battery (LiB) recycling process via a plant supply and technology licensing business model.
The provider of electronic and physical security systems announces at the AGM later today that the Chairman will confirm that good progress has continued in the current financial year ending April 2025. A new five-year growth plan is progressing and has involved several strategic hires to advanced new product development. The pipeline of new business opportunities is expanding in both divisions. A greater proportion of the Group's revenue will be recognised in the second half. At this current juncture, the Board remains confident in the full year outlook and achieving further growth.
The global provider of secure payment solutions for business communications announced its full year results for the year ended 30 June 2024. The Group saw positive adjusted EBITDA underpinned by revenue growth of 20% YoY to £17.96m and ARR increased 23% year on year to £15.5m. Cash at Period End of £4.33m.
The oil and gas engineering and services business announced a further update on the 1,550,000 convertible loan notes that were issued in October 2022 at £1 each to raise £1,550,000 for the Company. The Loan Notes had a two-year term and are repayable in cash or the issue of new ordinary shares in Plexus, subject to certain conditions. Following discussions between the Noteholders and the Company, it has been agreed that the maturity date for the remaining 700,008 Loan Notes will be extended for six months, until 19 April 2025.
The developer of novel immunotherapies for the treatment of cancer announced the appointment of Dr Phil L'Huillier as Chief Executive Officer. He will join the company and become a member of the Company's Board of Directors, effective 18 November 2024. Prior to joining Scancell, Dr L'Huillier served as CEO and Managing Director of CatalYm GmbH, a pioneering cancer immunotherapy company headquartered in Munich.
The footwear retailer announced its unaudited full year trading update for the 52 weeks to 28 September 2024. Group revenue reduced by 2.7% to £161.3m (FY 2023: £165.7m) and adjusted profit before tax expected is to be not less than £9.5m (FY 2023: £16.5m). Net cash was £3.7m (FY 2023: £16.4m) and a 2.5 pence per share interim dividend payment amounting to £1.2m was made in August 2024. A final dividend, the amount of which is yet to be determined, will be proposed in January 2025 alongside the final results.
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.